December 19, 2024 | NEJM
Image Challenge from the New England Journal of Medicine — December 19, 2024
Image Challenge from the New England Journal of Medicine — December 19, 2024
Taking a long-term view of cardiovascular disease prevention is an attractive strategy since atherosclerosis begins early in life and progresses over decades. Lowering low-density lipoprotein…
This brief reviews some of the possible actions of the incoming Trump administration and new Congress based on campaign statements, policies implemented by the first…
The mortality associated with acute lung injury (ALI) increases with age. Alveolar epithelial type II (AEII) cells are the progenitor cells of the alveolar epithelium…
Rationale: Patients who are critically ill and require admission to an intensive care unit (ICU) should receive the same quality of care regardless of their…
Rationale: Ground-glass opacities (GGOs) in the absence of interstitial lung disease are understudied. Objectives: To assess the association of GGOs with white blood cells (WBCs)…
In this column, KFF President and CEO Drew Altman examines the data and history around adding work requirements to Medicaid and why the administrative burdens…
This brief examines what the November election and prior efforts to enshrine abortion rights at the ballot box mean for those states and what’s next,…
Recognition of autism and autism diagnoses have increased substantially in recent years. But most nonautistic physicians don’t have the skills to effectively engage with autistic…
Depemokimab is an ultra-long-acting biologic therapy with enhanced binding affinity for interleukin-5 that may enable effective 6-month dosing intervals. In these phase 3A, randomized, placebo-cont…
The shift to videoconferencing since the start of the Covid-19 pandemic has transformed medical education. But the loss of many nonverbal cues during Internet-based interactions…